"Überlebensstrategien" lecture series
News
This lecture series is a joint project of the Heidelberg Collaborative Research Centres working in the life sciences and the Rhein-Neckar-Zeitung (RNZ).Professor Peter Schirmacher as speaker of the SFB/TR 209 will present the research topic of his SFB to the audience on 13th January 2022. The talk starts at 7:30 pm and will be held in the Karlstorbahnhof, Club K, Am Karlstor 1 in Heidelberg.
Scientific Seminars - Institute of Pathology and SFB/TR 209
News
Our first guest in the winter semester seminar series, Professor Andreas Geier (University Hospital Würzburg), will talk about “Targeting FGF19 signaling in liver disease“.
Scientific Seminars - Institute of Pathology and SFB/TR 209
News
We are happy to announce the next seminar series of the Institute of Pathology and the SFB/TR 209 for the winter semester. The seminar will take place in the big lecture hall (0.22) of the Institute of Pathology (INF 220/221) on Mondays, 17:15 h.
Latest publication
News
Scientists from the European Molecular Biology Laboratory (EMBL) and the German Cancer Research Center (DKFZ) have presented a new method for generating metabolic profiles of individual cells. The method, which combines fluorescence microscopy and a specific form of mass spectroscopy, can analyze over a hundred metabolites and lipids from more than a thousand individual cells per hour. Researchers expect the method to better answer a variety of biomedical questions in the future.
SFB/TR 209 Newsletter - Issue 5
News
The latest edition of our newsletter is available here...
Latest publication
News
Liver Cancer Tumors Appear to Be Resistant to Immunotherapy in Patients With Underlying Non-alcoholic Steatohepatitis (NASH) but very effective in Patients With viral hepatitis - Immunotherapy also appears to fuel tumor growth in these cancers.
Latest publication
News
LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancer.
Beijerinck Virology Prize
News
Prof. Dr. Ralf Bartenschlager received again a prestigious international award for his research on hepatitis C: The Beijerinck Virology Prize 2021 of the Royal Netherlands Academy of Arts and Sciences.
Poster prize
News
Noujan Ganjian, PhD student in project B08 (Longerich/Pellegrino) was awarded with the poster prize (session “Tumors”) of the 37th annual conference of the German Association of the Study of the Liver (GASL). The poster holds the title “Dissecting the molecular interplay between tumor cells and -stroma in primary liver cancer”.
Paris Hepatology Conference Award 2020
News
“Paris Hepatology Conference Award 2020” to Michael Manns.
Highly cited 2019 + 2020
News
Two of our project leaders appeared on the list of "Highly Cited Researchers". This international evaluation names researchers whose publications in their respective fields - a total of 21 disciplines in the natural, life and social sciences - have been cited most frequently worldwide or have produced outstanding publications across several disciplines.
SFB/TR 209 Newsletter - Issue 4
News
The latest edition of our newsletter is available here...Latest publication
News
Forschungsteam unter Tübinger Leitung identifiziert Molekülgruppe, die Gewebeverhärtungen steuert – Möglicher Ansatz zu Behandlung von Leberkrebs
Price winner
News
Our Gerok-stipend in Heidelberg, B. Köhler (project A04) was awarded with the Price of the Deutsche Leberstiftung 2019! CONGRATULATIONS
SFB/TR 209 Newsletter - Issue 3
News
The latest edition of our newsletter is available here...
50 Jahre SFBs
News
Im Jahr 2018 wird das Programm "Sonderforschungsbereiche" 50 Jahre alt. Die DFG feiert das - unter anderem mit einem Dossier mit zahlreichen Informationen zu diesem Programm, der Geschichte und Erfolgen sowie den beteiligten Wissenschaftlerinnen und Wissenschaftlern.
SFB/TR 209 Newsletter - Issue 2
News
The new edition of our newsletter is available here...
MD stipends available
News
The steering committee of the SFB/TR 209 decided to reward three MD stipends each year. Applications can be send any time.For further questions and details please contact Dr. M. Skunde.